The present invention is directed to compounds represented by Structural Formula (I) and pharmaceutically acceptable salts, solvates and hydrates thereof: (I). The invention is also directed to pharmaceutical compositions, methods of use and methods of making compounds represented by Structural Formula (I) and pharmaceutically acceptable salts, solvates and hydrates thereof.
本发明涉及由结构式(I)表示的化合物及其药学上可接受的盐、溶剂和
水合物:(I)。本发明还涉及由结构式(I)表示的化合物及其药学上可接受的盐、溶剂和
水合物的制备方法、药物组合物和使用方法。